-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - malignancies and/
or head and neck cancer (an off-
label use). … indicative of
its use in malignant neoplasms
of the genitourinary tract (e.g.,
bladder cancer). … both malignant neoplasm of pancreas
(157) and esophagus (150), appeared in
23 percent of beneficiaries … Sixty-seven
percent of beneficiaries with an imatinib
order had a prior diagnosis of malignant
neoplasm … Denileukin was accompanied by a prior diagnosis of malignant neoplasm
of lymphatic and hematopoietic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
January 01, 2011 - The total per claim reimbursement was
greatest for neoplasms, about $225 per
Carrier claim. … t
ho
us
an
d
2006 200920082007
Congenital anomalies
V-codes*
Infectious and parasitic diseases
Neoplasms … malignant neoplasm of trachea,
bronchus, and lung (162)
78,097 86,029 1,022.3
240-279 … malignant neoplasm of
female breast (174)
738,293 5,501,110 1,330.3
240-279
Endocrine … malignant neoplasm of trachea,
bronchus, and lung (162)
8,309 14,874 61.9
240-279
Endocrine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
June 01, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and
secondary malignancies … for CCS is critical to minimize and alleviate disparities due to
the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
August 10, 2016 - ) and squamous cell carcinoma (SCC),
are the most common malignancies in the U.S.1 BCC and SCC are collectively … Cancer Council Australia and
Australian Cancer Network. 2008.
26. … or "Oropharyngeal Neoplasms"[Mesh] OR Pharynx OR
Pharyngeal neoplasms OR "Pharyngeal Neoplasms"[Mesh … ] or "Lung Neoplasms"[Mesh]
or "Urinary Bladder Neoplasms"[Mesh] or "Uterine Cervical Neoplasms"[Mesh … ] or
"Esophageal Neoplasms"[Mesh] or "Laryngeal Neoplasms"[Mesh]))
AND
(((Surger* or surgic*) and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - [mh] OR neoplas* OR malignan* OR cancer OR
cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … [mh] OR neoplas* OR malignan* OR cancer OR
cancers OR cancerous OR tumor OR tumors OR tumour OR tumours … [mh] OR neoplas* OR malignan* OR cancer OR cancers OR cancerous OR tumor OR tumors
OR tumour OR tumours … visit,
date of report of
cancer, or death
Development of a
neoplasm as
evidenced in medical
records … Recurrence of
pituitary or CNS
tumors was
reported in 6
(1.4%) patients;
recurrence of other
neoplasias
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - analysis included all Medicare ben-
eficiaries with claims indicating a diagno-
sis in the malignant or benign … neoplasms
range of the ICD-9 codes (140-239) and
receipt of proton beam therapy (HCPCS
77520-77525 … cancers (Table 7). … Typically a prostate cancer case will have this daily
charge 30 times, and ocular tumor 5 times. … fur-
ther multiplied by the fact that with 6 to 8 weeks of therapy (compared
to one week for ocular neoplasms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - For example,
the literature for the use of HSCT in the hematologic malignancies is relatively robust … long-term effects (e.g., growth and development, cognitive
ability, future fertility, and secondary malignancies … Malignant Solid Tumors (Key Questions 1 and 2)
P: Pediatric patients with malignant solid tumors including … "[Mesh] OR (wilm* AND (tumor OR tumors OR
tumour*))
10:49:05 11596
#32 Search "therapeutic use … Search #72 NOT #5 11:24:57 3127
#72 Search (#70 AND #49) AND #32 11:20:04 3295
#70 Search ("Neoplasms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
September 26, 2023 - Background
Although anal cancer only represents1-2 percent of all gastrointestinal malignancies,
incidence … iliac nodes), M0
III T3-T4 (tumor >5cm in greatest dimension or tumor of any size invading … A., & American Joint Committee on Cancer Expert Panel on Cancers of the
Lower Gastrointestinal, Anus … ti,ab. 28776
22
10 Neoplasm grading/ or Neoplasm Invasiveness/ or Neoplasm Metastasis/ or … Neoplasm Recurrence, Local/ or Recurrence/ or neoplasm staging/ or Tumor Burden/ or
((neoplasm?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - Studies that report data by tumor (e.g., percentage of pancreatic adenocarcinoma tumors that
were correctly … Diagnostic management of pancreatic cancer. Cancers.
2011 Mar;3(1):494-509.
5. … exp pancreas, exocrine/) and (neoplasm/ or
adenocarcinoma/ or
neoplasms/)) or pancreas tumor/ or … r$ or sarcoma$ or neoplasm$
or
carcinoma$ or adenocarcinoma$)).mp.
4 neuroendocrine tumors/ and … and imaging and
diagnosis
17 and 23
25 Staging Cancer staging/ or Neoplasm staging/
26 ((mass
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
February 04, 2014 - Cancer Network.2 The
consensus definition of head and neck cancer includes tumors of:
• larynx; … cancer;
• esophageal cancer; and
• trachea tumors. … [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR
tumour [TIAB] OR tumours [TIAB] OR cancer [TIAB] OR cancers … "[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR
tumour [TIAB … "[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR
tumour [
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
July 09, 2024 - cancersb Solid tumor cancers, including breast, prostate, testicular,
cervical, and colon cancer. … Low risk of solid tumors in persons with Down
syndrome. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or
(hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or
Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - cancersb Solid tumor cancers, including breast, prostate, testicular,
cervical, and colon cancer. … Low risk of solid tumors in persons with Down
syndrome. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or
(hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or
Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
October 29, 2012 - Pediatric Oncologist, Pediatric Medical
Oncology
Memorial Sloan-Kettering Cancer Center
New York … , and high-risk relapsed Wilm’s tumor. … , Germ Cell and Embryonal"/ (256042)
33 ("germ cell tumor*" or "germ cell cancer" or "germ cell … / (617)
73 ("choroid plexus" and (tumor or tumour or tumors or tumours or neoplasm*)).mp. (1944) … , and high-risk
relapsed Wilm’s tumor.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
February 22, 2012 - and Endobronchial Obstruction Due to Advanced Lung Tumors
I. … recurrence, noncancer-related mortality, and second malignancies.2, 3
Malignant Endobronchial Obstruction … Intraoperative seed placement for thoracic
malignancy-A review of technique, indications, and published … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non-
small-cell' OR 'non-small cell' OR 'non … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non-
small-cell' OR 'non-small cell' OR 'non
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - non-dermatologic malignancy (174,650 new cases) and the second
leading cause of cancer death (31,620 … With AS, tumors are not
immediately removed, irradiated, or ablated.3, 4 Instead, tumors are monitored … Stage 1
T2= tumor Stage 2
T3= tumor Stage 3
T4= tumor Stage 4
WMD= weighted mean differences
WW … / (121506)
2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514)
3 watchful … / (9241)
2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - die with hepatic metastases.1 Colorectal cancer is the most
common malignancy that metastasizes to … "[Mesh] OR ((hepatic OR liver) AND (cancer OR cancers OR oncology
OR neoplasms)) AND "Colorectal Neoplasms … OR cancers OR oncology OR neoplasms AND
colon OR colorectal OR rectal OR intestinal OR rectum OR intestine … Is Extended Hepatectomy for Hepatobiliary
Malignancy Justified? Ann Surg 2004;239(5):722-32. … Antiangiogenic agents in advanced gastrointestinal
malignancies: past, present and a novel future.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
October 14, 2011 - (particularly cancerous tumors with aggressive features)? … Indolent Cancers of the Prostate (Key Question 3)
Figure 2. … ] (OR text words “prostate cancer”, “prostatic
cancer”, “prostate neoplasms”, “prostatic neoplasms” … Characteristics
Age
Race
Benign prostatic hyperplasia
High-grade prostatic intraepithelial neoplasia … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR
"prostatic cancer" OR "prostate cancer"
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia.7 Patients
with hematological malignancies … versus hematological malignancies versus mixed (studies
including both solid tumors and hematological … * OR tumor OR tumors OR tumour* OR neoplas* OR
carcinom*
#59 Search erythropoietin OR epoetin* OR … "[Mesh] OR "Carcinoma"[Mesh] OR malignan* OR cancer OR cancers OR
cancerous OR oncolog* OR myelodysplas … * OR tumor OR tumors OR tumour* OR neoplas* OR
carcinom*)
AND
("adverse effects "[Subheading
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - KQ 5: What is the risk of malignancy associated with rhGH use as determined by: a)
markers of cancer … decreases
over 1000 ng/ml) from studies of rhGH in people with CF and by b) assessment of evidence
on cancer … Neoplasms/
39. neoplas$.mp.
40. malignan$.mp.
41. cancer.mp.
42. tumor.mp.
43. … Neoplasms/
14. neoplas$.mp.
15. malignan$.mp.
16. cancer.mp.
17. tumor.mp.
18. … Neoplasms/
46. neoplas$.mp.
47. malignan$.mp.
48. cancer.mp.
49. tumor.mp.
50.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - studies have
shown that prognosis can vary substantially.5-8 Brain metastases occur with a variety of
cancers … While treatment for brain metastases from other primary cancers
and in pediatric patients is equally … Epidemiology of metastatic brain tumors. … Effect of tumor subtype on survival and the
graded prognostic assessment for patients with breast cancer … OR cancer* OR neoplasm* OR
carcinoma* OR metastasectomy)))
AND
(MH "Radiosurgery") OR TI(radiation